Current role
Biotechnology · Healthcare
COO, General Counsel
2026-04-15–present
Matthew Lang
General Counsel
Structure Therapeutics Inc. (GPCR)Equibles does not estimate personal net worth.
Get an email with a short summary when Structure Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get GPCR alertsAbout Matthew Lang
Matthew Lang is recorded as General Counsel at Structure Therapeutics Inc. (GPCR) since April 15, 2026 and COO at Structure Therapeutics Inc. (GPCR). The newest filing on record that lists Matthew Lang as COO at Structure Therapeutics Inc. (GPCR) is dated April 23, 2026. Structure Therapeutics Inc. reported in an 8-K filed April 15, 2026 that Matthew Lang was appointed Chief Operating Officer and General Counsel, effective April 15, 2026. Structure Therapeutics Inc. reported in an 8-K filed April 15, 2026 that Matthew Lang was appointed Chief Operating Officer and General Counsel, effective April 15, 2026. Structure Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Structure Therapeutics Inc. includes Raymond Stevens (CEO and Board Member), Jun Yoon (CFO), Yingli Ma (CTO) and 2 others.
“Matthew Lang was appointed as Structure Therapeutics, Inc.'s (the "Company") Chief Operating Officer and General Counsel, effective April 15, 2026.”
“Matthew Lang was appointed as Structure Therapeutics, Inc.'s (the "Company") Chief Operating Officer and General Counsel, effective April 15, 2026.”
Affiliation history
-
Current
2026-04-15–present
-
Current
Start not stated–present
Last confirmed April 23, 2026
Company network
Leadership on record at Structure Therapeutics Inc.
- Raymond Stevens CEO, Board Member
- Jun Yoon CFO
- Yingli Ma CTO
- Angus Russell Board Member
- Ted Love, M.D. Board Member